Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against Fortrea Holdings Inc. due to allegations of misleading statements and financial misrepresentations that have negatively impacted investors [3][5]. Group 1: Legal Investigation and Claims - Investors who suffered losses exceeding $50,000 in Fortrea between July 3, 2023, and February 28, 2025, are encouraged to contact Faruqi & Faruqi to discuss their legal options [1]. - A federal securities class action has been filed against Fortrea, with a deadline of August 1, 2025, for investors to seek the role of lead plaintiff [3]. Group 2: Allegations Against Fortrea - The complaint alleges that Fortrea overestimated revenue contributions from Pre-Spin Projects and overstated cost savings from exiting Transition Services Agreements (TSAs), leading to inflated EBITDA targets for 2025 [5]. - The company's public statements regarding its business model and financial prospects were claimed to be materially false and misleading [5]. Group 3: Stock Performance and Analyst Downgrades - On September 25, 2024, Jefferies downgraded Fortrea from buy to hold, citing weaknesses in the business model and a subsequent stock price drop of $2.73 per share (12.29%) to close at $19.48 [6]. - Baird Equity Research downgraded Fortrea to neutral on December 6, 2024, after the company canceled two scheduled conferences, resulting in a stock price decline of $1.90 per share (8.06%) to close at $21.67 [7]. - Following the announcement of disappointing financial results on March 3, 2025, Fortrea's stock fell by $3.47 per share (25.05%) to close at $10.38, with the company acknowledging that its revenue and EBITDA expectations for 2025 were not met [8].

撰文丨王聪 编辑丨王多鱼 排版丨水成文 表型可塑性 （ Phenotypic plasticity ） 是驱动癌症进展、转移和治疗耐药性的显著特征。胎儿样 （ Fetal-like ） 转录程序在促进细胞的可塑性状态方面的作用 日益受到关注，但由于现有培养模型的局限性，其作用仍难以研究。 2025 年 7 月 4 日，北京大学 邓宏魁 教授、 屈默龙 副研究员、北京大学首钢医院/北京大学肿瘤医院 顾晋 教授团队 （ 熊亮 、 徐莹 、 高兆亚 为共同第一作 者 ） 在 Cell Research 期刊发表了题为 ： A patient-derived organoid model captures fetal-like plasticity in colorectal cancer 的研究论文。 该研究开发了一种 化学成分明确的患者来源的类器官系统 （ CiPDO ） ，并用该类器官系统捕捉到了 结直肠癌 的 胎儿样可塑性 状态 。 在这项最新研究中，研究团队建立了一种 化学成分明确的患者来源的类器官系统 （ CiPDO ） ，培养条件是 EGF + CHIR99021 （Wnt激动剂） + LDN- 214 ...

图片来源： a16z Z Highlights AI 推动市场调研迈入新纪元 几十年来，企业为更好地了解客户，持续向市场调研投入了数千亿美元，但却一直受到调查慢、样本偏倚、洞察滞后的制约。尽管每年市场调研的支出高 达 1400 亿美元，但软件的使用在其中几乎可以忽略不计。举例来说，传统依赖人工的咨询公司如 Gartner 和 McKinsey 估值分别为 400 亿美元，而软件平 台 Qualtrics 和 Medallia 的估值仅为 125 亿美元和 64 亿美元。 随着 AI 的发展，我们又一次看到市场准备将原本用于人工的支出转向软件。早期的 AI 公司已经开始利用语音转文字（ speech-to-text ）和文字转语音（ text-to-speech ）模型，构建 AI 原生的调查平台 —— 这些平台可以自动进行视频访谈，然后由大型语言模型（ LLMs ）分析结果并生成演示文稿。 这些先 行者增长迅速，不仅签下了大型合同，还开始接管原本由市场调研和咨询公司掌控的预算。 McKinsey 等咨询公司构建了完整的调研子部门，使用软件化工具进行大规模客户细分和消费者洞察。但这种合作常常历时数月、成本高昂、 ...

南方财经记者 李金萍 深圳报道 从行业类别看，新落地外资企业主要分布在批发和零售业、租赁和商务服务业和科学研究和技术服务 业，三者占新设外资企业数量的七成以上。其中科学研究和技术服务业增速最快，增长超过60%。 福田正在通过外商服务站、联动10个街道服务分站点与N个外资总部楼宇，围绕金融、科技、总部经济 等外资企业集聚区，吸引和服务外资企业。 目前，福田已建成6个街道外商服务点，今年将实现10个街道全覆盖；上半年，外商服务站累计解决咨 询 128 件，服务超 50 家外资企业。 伦敦发展促进署华南副总裁黎喻（Lesley Li）表示，福田区的服务效率与产业生态令人印象深刻，考察 调研活动将纳入其全球推广案例，助力深圳打造国际金融科技中心。 数据显示，福田拥有外资企业已达1.75万家，5家企业申报为第九批深圳市级跨国公司总部认定企业， 居深圳市首位。 福田外商服务站相关工作人员告诉南方财经记者，新设外资企业在深圳投资更关注政策匹配度、跨境便 利性、产业空间适配等内容。 深圳引进外资企业又有了新动向。 7月4日，记者从深圳市福田区获悉，今年1—5月，该区新设外资企业1039家，同比增长28.91%，占深 圳市新设 ...

NEW YORK, July 04, 2025 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against Fortrea Holdings Inc. (NASDAQ: FTRE) and certain of the Company’s senior executives for potential violations of the federal securities laws. If you invested in Fortrea you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/fortrea-holdings-inc-class-action-lawsuit. Investors have until August 1, 2025, to ask th ...

NEW YORK, July 3, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Fortrea Holdings Inc. (NASDAQ: FTRE).Shareholders who purchased shares of FTRE during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.CONTACT US HERE:https://securitiesclasslaw.com/securities/fortrea-holdings-inc-loss-submission-form/?id=155236&from=4CLASS PERIOD: July 3, 202 ...

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential claims against Fortrea Holdings Inc. due to allegations of misleading statements and financial misrepresentations that have negatively impacted investors [2][4]. Group 1: Legal Investigation and Class Action - Faruqi & Faruqi is encouraging investors who suffered losses in Fortrea to contact them regarding their legal rights, particularly for those who purchased securities between July 3, 2023, and February 28, 2025 [1][2]. - There is an August 1, 2025 deadline for investors to seek the role of lead plaintiff in a federal securities class action against Fortrea [2][4]. Group 2: Allegations Against Fortrea - The complaint alleges that Fortrea and its executives violated federal securities laws by making false statements and failing to disclose critical information, including overestimating revenue contributions from Pre-Spin Projects and overstating cost savings from exiting TSAs [4]. - The company's previously announced EBITDA targets for 2025 were inflated, leading to an overstatement of its business model viability and financial prospects [4]. Group 3: Stock Performance and Analyst Downgrades - On September 25, 2024, Jefferies downgraded Fortrea from buy to hold, citing weaknesses in the business model and a stock price drop of $2.73 per share (12.29%) to close at $19.48 [5]. - Following the cancellation of two scheduled conferences, Baird Equity Research downgraded Fortrea to neutral on December 6, 2024, resulting in a stock price decline of $1.90 per share (8.06%) to close at $21.67 [6]. - On March 3, 2025, Fortrea announced disappointing financial results, revealing that its revenue and adjusted EBITDA expectations for 2025 were not met, leading to a significant stock price drop of $3.47 per share (25.05%) to close at $10.38 [7].

Core Viewpoint - A lawsuit has been filed against Fortrea Holdings Inc. and its senior executives for potential violations of federal securities laws, specifically related to the company's financial disclosures and performance claims [1][2]. Company Overview - Fortrea Holdings Inc. is a global contract research organization that provides biopharmaceutical product and medical device development solutions. It was spun off from Labcorp Holdings Inc. in June 2023 and entered into transition services agreements with Labcorp [3]. Allegations - The lawsuit alleges that Fortrea overstated the cost savings and margin improvements expected from exiting the transition services agreements, as well as the revenue from pre-spin projects [4]. Stock Performance - Following a report from Jefferies on September 25, 2024, which indicated that the anticipated cost savings were not as significant as previously thought, Fortrea's stock price fell by $2.73, or over 12%, from $22.21 to $19.48 [5]. - On March 3, 2025, Fortrea announced disappointing financial results for Q4 and the full year 2024, leading to a further decline in stock price by $3.47, or over 25%, from $13.85 to $10.38 [6].

Group 1 - Moretus Research provides high-quality equity research focused on U.S. public markets, aiming to deliver clarity, conviction, and alpha for serious investors [1] - The research framework identifies companies with durable business models, mispriced cash flow potential, and intelligent capital allocation, emphasizing a structured and repeatable approach [1] - Valuation methods are based on sector-relevant multiples tailored to each company's business model and capital structure, prioritizing comparability, simplicity, and relevance [1] Group 2 - Research coverage focuses on underappreciated companies experiencing structural changes or temporary dislocations, where disciplined analysis can yield asymmetric returns [1] - Moretus Research aims to elevate the standard for independent investment research by providing professional-grade insights and actionable valuations [1]

🚨 ANALYSTS WANTED!Be the next @RyanWatkins_, @masonnystrom, @Old_Samster.Deadline: July 8thSalary and details 👇Luis Rincon (@luisri_):The leaderboard says it all.Come build the future of crypto research at @MessariCrypto.Want in? Apply by July 8 → start Aug 19.https://t.co/DGQSXBN0ET ...